EUVIMEDEUVIMED entdecken
Fallbericht

How we treat relapsed refractory gestational trophoblastic neoplasms—An exciting case series

Kritthivasan Venkatakrishnan, Jayachandran Perumal Kalaiyarasi iD, Jayashree Natarajan, Amy Jose, Ujwala Wakpaijan, Gangothri Selvarajan, Sridevi Velusamy

International Journal of Gynecology & Obstetrics · 2025

DOI: 10.1002/ijgo.70032 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Kritthivasan Venkatakrishnan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Cancer Institute (W.I.A), Chennai, India. Hauptthemen laut MEDLINE: Gestational Trophoblastic Disease, Neoplasm Recurrence, Local. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Relapsed/refractory gestational trophoblastic neoplasia (RR‐GTN) presents a significant therapeutic challenge, with limited options available for patients who fail first‐line treatments. In the present study we describe a few unique cases of RR‐GTN and various options available for such situations.

Methods

We identified three cases of RR‐GTN between January 2021 and December 2022 who failed two or more lines of standard treatment. Clinical characteristics, therapeutic regimens, toxicities, and outcomes were collected from the case records.

Results

We present this case series of three patients with RR‐GTN treated with distinct therapeutic approaches: (1) Surgery for localized disease, (2) immunotherapy with pembrolizumab, and (3) tandem autologous stem cell transplantations. We also provide a detailed review of the available literature and guidance on managing RR‐GTN.

Conclusion

Intensified chemotherapy regimens, immune checkpoint inhibitors, and autologous stem cell transplantation offer promising avenues for improving outcomes in these high‐risk patients. Clinical trials are warranted to establish the optimal sequencing of these therapies in clinical practice, but it may not be possible due to the paucity of such clinical situations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gestational Trophoblastic DiseaseNeoplasm Recurrence, LocalHumansFemalePregnancyAdultAntibodies, Monoclonal, HumanizedStem Cell TransplantationImmunotherapy

Stichwörter der Autor:innen

autologous stem cell transplantation in GTNhigh dose chemotherapy in GTNpembrolizumab in GTNrelapsed/refractory gestational trophoblastic neoplasmrestoration of chemosensitivity with PD‐1 inhibitors

Substanzen

pembrolizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Medical Oncology, Cancer Institute (W.I.A), Chennai, India.
  • Division of Gynecologic Oncology, Department of Surgical Oncology, Cancer Institute (W.I.A), Chennai, India.
  • Department of Surgical Oncology, Cancer Institute (W.I.A), Chennai, India.

ORCID-Profile: Jayachandran Perumal Kalaiyarasi

Zitieren

APA

Venkatakrishnan, K., Perumal Kalaiyarasi, J., Natarajan, J., Jose, A., Wakpaijan, U., Selvarajan, G., & Velusamy, S. (2025). How we treat relapsed refractory gestational trophoblastic neoplasms—An exciting case series. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70032

Vancouver

Venkatakrishnan K, Perumal Kalaiyarasi J, Natarajan J, Jose A, Wakpaijan U, Selvarajan G, et al. How we treat relapsed refractory gestational trophoblastic neoplasms—An exciting case series. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70032

BibTeX
@article{Venkatakrishnan2025,
  author = {Venkatakrishnan, Kritthivasan and Perumal Kalaiyarasi, Jayachandran and Natarajan, Jayashree and Jose, Amy and Wakpaijan, Ujwala and Selvarajan, Gangothri and Velusamy, Sridevi},
  title = {How we treat relapsed refractory gestational trophoblastic neoplasms—An exciting case series},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  doi = {10.1002/ijgo.70032}
}
Kostenlos starten →